AI Stock Analysis - Tilray (TLRY)
Analysis generated October 14, 2025.
Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The company is among the leaders in the global cannabis market and is committed to advancing the quality of life for patients and consumers through safer, better, and more consistent pharmaceutical-grade cannabinoids. Headquartered in Canada, Tilray operates through various subsidiaries in different regions, offering a wide range of products including medical cannabis, adult-use cannabis, and hemp-based foods and wellness products.
Stock Alerts - Tilray (TLRY)
 |
Tilray | January 22 Price is up by 7% in the last 24h. |
|
Tilray | January 20 Price is down by -6.4% in the last 24h. |
|
Tilray | January 14 Price is up by 6.4% in the last 24h. |
|
Tilray | January 12 Price is up by 6.6% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Tilray
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 72 | Sign up | Sign up | Sign up |
| Sentiment | 80 | Sign up | Sign up | Sign up |
| Webpage traffic | 36,000 | Sign up | Sign up | Sign up |
| Employee Rating | 56 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 782 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 156,482 | Sign up | Sign up | Sign up |
| X Followers | 34,793 | Sign up | Sign up | Sign up |
| X Mentions | 25 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 26 | Sign up | Sign up | Sign up |
| Linkedin Employees | 971 | Sign up | Sign up | Sign up |
About Tilray
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
| Price | $8.42 |
| Target Price | Sign up |
| Volume | 3,660,000 |
| Market Cap | $1.05B |
| Year Range | $3.6 - $21 |
| Dividend Yield | 0% |
| Analyst Rating | 29% buy |
| Industry | Medical Cannabis |
In the news
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis PortfolioJanuary 22 - GlobeNewswire |
|
 |
Tilray management to meet with Roth CapitalJanuary 20 - Thefly.com |
 |
Tilray price target lowered by $10 at Roth Capital, here's whyJanuary 20 - Thefly.com |
 |
Mixed options sentiment in Tilray with shares up 1.08%January 13 - Thefly.com |
International Cannabis Expansion Gives Tilray Positive 2026 OutlookJanuary 9 - SeekingAlpha |
|
|
Tilray price target lowered by $10 at Alliance Global, here's whyJanuary 9 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 218M | 160M | 57M | -44M | -22M | -0.020 |
| Q3 '25 | 288M | 209M | 79M | -440,000 | 30M | 0.000 |
| Q2 '25 | 308M | 215M | 93M | -1.75B | -1.84B | 0.020 |
| Q1 '25 | 268M | 193M | 75M | -1.14B | -1.08B | -0.869 |
| Q4 '24 | 295M | 209M | 86M | -119M | -58M | -0.003 |
Insider Transactions View All
| Gendel Mitchell filed to buy 698,287 shares at $0.6. August 4 '25 |
| Merton Carl A filed to buy 798,069 shares at $0.6. July 30 '25 |
| SIMON IRWIN D filed to buy 3,941,633 shares at $0.6. July 30 '25 |
| Merton Carl A filed to buy 26,000 shares at $1.4. November 18 '24 |
| FALTISCHEK DENISE M filed to buy 293,269 shares at $2.1. January 18 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Canopy GrowthCGC |
$1.17 1.7% | 29 |
 |
Aurora CannabisACB |
$4.42 2.3% | 30 |
 |
Sundial GrowersSNDL |
$1.6 0.6% | 35 |
 |
OrganigramOGI |
$1.65 3.1% | 35 |
 |
Cronos GroupCRON |
$2.71 0.7% | 41 |
Read more about Tilray (TLRY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Tilray
The Market Cap of Tilray is $1.05B.
Currently, the price of one share of Tilray stock is $8.42.
The TLRY stock price chart above provides a comprehensive visual representation of Tilray's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tilray shares. Our platform offers an up-to-date TLRY stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Tilray (TLRY) does not offer dividends to its shareholders. Investors interested in Tilray should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Tilray are Canopy Growth, Aurora Cannabis, Sundial Growers, Organigram, and Cronos Group.
